JPRN-UMIN000012564已完成未知
Phase II trial of embolization with NBCA-lipiodol mixture (JIVROSG-0802) - Phase II trial of NBCA (JIVROSG-0802)
Japan Interventional Radiology In Oncology Study Group(JIVROSG)0 个研究点目标入组 65 人开始时间: 2013年12月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 65
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Allergic histories for iodininated contrast medium or lipiodol. 2. CNS arteriovenous malformation 3. Cerebral aneurysm 4. DIC 5. Uncontrollable shock 6. Endoleak after aortic stent placement 7. Pregnant woman, or pegnancy is suspected 8. Radiologist judged that the patients is not suitable for the present study.
研究者
相似试验
已完成
2 期
Phase II trial of Transarterial Chemoembolization using Drug-eluting bead for advanced HCC refractory to Lipiodol-TACEadvanced hepatocellular carcinomaJPRN-UMIN000015463Clinical Research Group of the Japanese Society for Transcatheter Hepatic Arterial Embolization24
进行中（未招募）
不适用
Phase II study evaluating transarterial chemoembolization (TACE) in combination with sorafenib for the treatment of advanced hepatocellular carcinoma (HCC) - TACE and sorafenib for HCChistologically proven advanced hepatocellular carcinoma (HCC) not suitable for resection or liver transplantation but without extrahepatic manifestations and without previous treatment for HCCMedDRA version: 9.1Level: LLTClassification code 10019828Term: Hepatocellular carcinoma non-resectableEUCTR2007-000730-40-DEHeinrich-Heine-Universität Düsseldorf
招募中
2 期
The effect of Percutaneous embolization in patients with symptomatic liver hemangiomasIRCT20130812014333N154Kermanshah University of Medical Sciences19
已完成
不适用
Clinical outcomes of endovascular embolization for the treatment of Spinal ArterioVenous Malformations (AVMs)IRCT2014071218457N1Vice chancellor for research, Imam Khomeini Hospital, Tehran University of Medical Sciences (TUMS)36
招募中
2 期
Phase II trial of palliative intra-arterial epirubicin/5FU therapy for patients with chemotherapy-refractory locally-advanced or metastatic breast cancerlocally-advanced and metastatic breast cancerJPRN-UMIN000013242Japan Interventional Radiology in Oncology Study Group (JIVROSG)30